CA-VELODYNE-LIDAR,-INC.
16.6.2020 14:02:13 CEST | Business Wire | Press release
Velodyne Lidar, Inc. today announced a multi-year partnership agreement with Outsight, the company that is a leading innovator in Smart Cities monitoring. Outsight uses Velodyne Lidar sensing technology in its 3D Semantic Camera system that helps businesses and governments improve the analysis and management of people flow and assets in large crowded environments.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200616005074/en/
Velodyne’s lidar sensors enable the 3D Semantic Camera solution to capture 3D data and track people and objects in a way that preserves anonymity and trust. The autonomous system merges lidar data capture with RGB color data with an embedded AI processing unit to create a premises-wide, detailed situational understanding of facilities, such as airports, shopping malls and train stations.
In a Smart City application, 3D Semantic Cameras provide operators of public spaces access to real-time data and analysis without compromising private data protection. The solution is being deployed at Paris-Charles de Gaulle airport to optimize the passenger journey, improve queue and asset management, and enhance compliance and safety.
Outsight’s 3D Semantic Cameras can also be deployed to support social distancing and public health. The solution can track individuals based on selected criteria, such as lack of physical distancing, high temperature or not wearing a mask, without having to visually identify them. The Outsight device then can alert the operator when an abnormal event is detected, saving time and resources while optimizing crowd flows.
“Velodyne’s lidar sensors play an essential role in helping our platform capture, process and understand congested environments so operators can work to increase operational efficiency and security,” said Cedric Hutchings, CEO, Outsight. “The Velodyne lidar sensors allow us to track each individual person and object with centimeter-level precision. They enable our solutions to precisely monitor movements, velocity and interactions between all persons and objects in real time.”
“Outsight uses Velodyne’s lidar technology to bring a totally new approach to real-time situational awareness on what’s happening in busy spaces, such as airports,” said Jon Barad, Vice President of Business Development, Velodyne Lidar. “Their system helps organizations move away from traditional surveillance to create a more intelligent infrastructure that tracks people and objects in a more reliable way.”
About Velodyne Lidar
Velodyne provides smart, powerful lidar solutions for autonomy and driver assistance. Headquartered in San Jose, Calif., Velodyne is known worldwide for its portfolio of breakthrough lidar sensor technologies. Velodyne’s founder, David Hall, invented real-time surround view lidar systems in 2005 as part of Velodyne Acoustics. Mr. Hall’s invention revolutionized perception and autonomy for automotive, new mobility, mapping, robotics, and security. Velodyne’s high-performance product line includes a broad range of sensing solutions, including the cost-effective Puck™, the versatile Ultra Puck™, the autonomy-advancing Alpha Prime™, the ADAS-optimized Velarray™, and the groundbreaking software for driver assistance, Vella™.
About Outsight
Outsight develops a 3D Semantic Camera, a revolutionary kind of sensor that brings Full Situation Awareness to Smart Machines and Monitoring Solutions. This sensor combines software and hardware to create sensor innovations such as remote material identification with comprehensive real-time 3D data processing. This technology provides an unprecedented and cost-efficient ability for systems to perceive, understand and ultimately interact with their surroundings in real time. Outsight believes in making a smarter and safer world by empowering cars, drones, robots and monitoring solutions with the superhuman capabilities provided by their 3D Semantic Camera. Their international team of scientists and engineers operates out of Paris, Helsinki and San Francisco.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200616005074/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Empire State Building Observation Deck to Debut ‘Olympus Awaits,’ An Immersive ‘Percy Jackson and the Olympians’ Takeover in the Heart of NYC, On Display from Nov. 16 – Dec. 4*12.11.2026 23:07:00 CET | Press release
The multi-level takeover includes a Throne Room, interactive photo opportunities, special lighting, and more The Empire State Building (ESB) is the gateway to Mount Olympus in Percy Jackson’s world, and now fans can experience the magic like never before. On Nov. 16, the Empire State Building Observation Deck (ESBOD) will unveil “Olympus Awaits,” a multi-level “Percy Jackson and the Olympians” takeover, in partnership with Disney+. The immersive takeover – included with every Observation Deck ticket – will feature an epic Throne Room, interactive photo opportunities, surprise giveaways, ESB x “Percy Jackson” merch, and more, available through Dec. 4, 2026.* This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112442266/en/ Empire State Building Observation Deck to Debut ‘Olympus Awaits,’ An Immersive ‘Percy Jackson and the Olympians’ Takeover in the Heart of NYC, On Display from Nov. 16 – Dec. 4* “This immersive NYC experience
Clene Nanomedicine Partners with Veristat to Reduce Biostatistical Output Time by 80% for ALS New Drug Application12.11.2026 18:09:00 CET | Press release
Veristat’s InStat™ delivers submission-ready tables, listings, and figures (TLFs) in one week using validated statistical engines, shortening the critical path from database lock to submission VeristatTM, a global clinical research organization (CRO) and consultancy specializing in complex studies, announced that it has partnered with Clene Nanomedicine to cut the time to deliver biostatistical outputs for a pivotal ALS drug application submission by 80%. Veristat reduced the time from study data to validated tables, listings and figures (TLFs) from up to six weeks to just one week. Clene, a late-stage biotech company, leveraged Veristat’s recently launched InStat™ platform, the industry’s first zero-code, fully automated solution to accelerate clinical trial processes. Biostatistical TLFs sit on the critical path for submissions, yet most sponsors rely on antiquated processes that involve slow, manual workflows to produce them, making post-database lock one of the biggest bottlenecks
WHOOP Launches WHOOP Humans, the Most Verifiably Human Social Network12.11.2026 18:00:00 CET | Press release
New feature lets members follow friends and family, share performance and health insights, and celebrate life's moments together WHOOP, the human performance brand, today launched WHOOP Humans, a new feature that lets members follow friends and family, share fitness, health, and performance data they choose, and support each other's progress. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112176779/en/ WHOOP Launches WHOOP Humans, the Most Verifiably Human Social Network For more than a decade, WHOOP has helped members better understand their own health and performance. Now, WHOOP Humans extends that experience beyond the individual, making it easier to celebrate achievements, encourage progress, and look out for the people who matter most. "In a world that's becoming increasingly artificial, we're building something deeply human,” said Will Ahmed, Founder and CEO of WHOOP. “This is the most verifiably human network ever
Integrated Hubs for Green Chemistry Research Aim to Transform How Chemicals and Materials Are Designed12.11.2026 17:00:00 CET | Press release
International network will investigate fundamental principles for creating safer, higher-performing chemicals and materials The Gordon and Betty Moore Foundation today announced four Integrated Research Hubs to explore new frontiers in chemical design, from materials that respond to their surroundings to molecules designed for safety from the start. Bringing together global researchers across institutions and disciplines, the hubs will investigate fundamental principles that could enable new capabilities in chemicals and materials while improving performance and protecting human health and the environment. The research priorities emerged through extensive engagement with the scientific community to identify the questions that could transform what chemistry can achieve. Each hub will connect researchers across institutions around one of four green chemistry focus areas: Safer molecular design: Led by The George Washington University, this hub will combine artificial intelligence and qua
Roquette Highlights Scalable Excipient and Capsule Solutions for Regional and Global Pharmaceutical Markets at CPHI India 202612.11.2026 16:00:00 CET | Press release
Helping pharmaceutical manufacturers accelerate the journey from formulation to market through deep technical expertise, meaningful innovation, close collaboration and global capabilities Roquette, a global leader in plant-based ingredients and a leading provider of pharmaceutical excipients, will showcase its comprehensive portfolio of excipient and capsule solutions at CPHI India 2026, Hall 1, Booth 1I12 from November 23 to 25, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112803410/en/ Meet Roquette at CPHI India 2026, Hall 1, Booth 1I12 At the event, Roquette will demonstrate how it helps pharmaceutical manufacturers accelerate the journey from formulation to market with confidence. By combining technical expertise, trusted quality, meaningful innovation and close collaboration, Roquette helps customers address formulation, scale-up and manufacturing challenges across a broad range of pharmaceutical application
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom